Biopartnering Seminar - New Digital Strategies for Clinical Trial Enrolment - Are They Worth It?

WinNovys Team Photo
Tuesday, November 24, 2015 - 6:30pm
New Digital Strategies for Clinical Trial Enrolment - Are They Worth It?, WinNovys - MBiotech Student Team

Tuesday, November 24, 2015, 6:30pm.
Room 120, Instructional Building.

Clinical trials have proven to be an essential process for translating scientific innovation into advances in modern health care and improvements to quality of life. These human experiments often serve as a final checkpoint before a new drug can be made accessible as treatment for the public. However, a dense regulatory field and multiple barriers to patient enrolment weigh tremendously on the research, health care, and the biopharmaceutical industry; up to 90% of clinical trials fail to meet recruitment deadlines and up to 40% of the total clinical trial costs are incurred in recruitment. Our research identifies three primary pillars to ameliorate difficulties faced in traditional procedures for clinical enrolment: increased patient awareness, a patient-centric approach to accessibility, and efficient patient education on the trial. We aim to describe the current environment of and to provide strategic insights to the digital tools that can be used to improve clinical trial enrolment. After evaluating notable examples of digital strategies used for clinical enrolment and analysis of various digital tools used in industries outside of health care, we propose that a shift towards more integrative patient-centric approaches using digital strategies to address patient awareness, trial accessibility, and patient understanding to improve clinical trial enrolment rates. Next, we forecast financial outcomes to demonstrate the economic value of increased enrolment via digital supplementation. Finally, the potential future of digital strategies for clinical enrolment is discussed. Our research explores the dynamic field of digital tools and provides strategic insights into addressing the demanding burdens of patient enrolment for clinical trials.

This seminar will be open to the public.

This seminar is part of the Biopartnering Seminar Series, offered by the Master of Biotechnology Program.